Clinical trial
Allogeneic Transplantation Using Mini-Conditioning for Treatment of Stage IV…
NCT00006261 · Case Comprehensive Cancer Center, Other · Withdrawn
Key facts
| NCT number | NCT00006261 |
|---|---|
| Title | Allogeneic Transplantation Using Mini-Conditioning for Treatment of Stage IV Breast Cancer |
| Official title | Allogeneic Transplantation Using Mini-Conditioning for Treatment of Stage IV Breast Cancer |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological, Drug, Procedure |
| Interventions | therapeutic allogeneic lymphocytes, cyclophosphamide, docetaxel, doxorubicin hydrochloride, fludarabine phosphate, peripheral blood stem cell transplantation |
| Enrollment | 0 |
| Start date | May 1, 2000 |
| First posted | Apr 29, 2004 |
| Last update posted | Jun 10, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: